...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms.
【24h】

Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms.

机译:人腹主动脉瘤壁血栓内纤溶系统的拓扑结构。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Development and progression of acquired abdominal aortic aneurysms (AAAs) involve proteolytic activity. In the present study, we investigate the distribution of fibrinolytic system components within mural thrombi of human AAAs. 20 mural thrombi and the remaining AAA walls were dissected. The luminal, intermediate and abluminal thrombus layers, and media and adventitia were separately incubated in cell culture medium. Conditioned media were then analysed for plasminogen activators (PAs), plasminogen activator inhibitor-1 (PAI-1), free-plasmin, plasmin alpha(2)-antiplasmin complexes (PAPs) and D-dimers release. In parallel, PA and PAI-1 mRNA expression analysis was performed by RT-PCR. The study was completed by immunohistochemical localization of these components in AAA, ex vivo functional imaging using (99m)Tc-aprotinin as a ligand and measurement of PAP and D-dimer plasma levels. All fibrinolytic system components were present in each aneurysmal layer. However, the mural thrombus was the main source of active serine-protease release. Interestingly, the luminal layer of the thrombus released greater amounts of PAPs and D-dimers. This paralleled the preferential immunolocalization of plasminogen and PAs, and the (99m)Tc-aprotinin scintigraphic signal observed in the luminal pole of the thrombus. In contrast, mRNA expression analysis showed an exclusive synthesis of tPA and PAI-1 within the wall, whereas uPA mRNA was also expressed within the thrombus. Taken together, these results suggest that the increased plasma concentrations of PAPs and D-dimers found in AAA patients are related to mural thrombus proteolytic activity, thus explaining their known link with AAA progression. Components of the fibrinolytic system could also represent a target for functional imaging of thrombus activities in AAA. Published by John Wiley & Sons, Ltd.
机译:获得性腹主动脉瘤(AAAs)的发育和进展涉及蛋白水解活性。在本研究中,我们调查了人类AAAs的壁血栓内纤溶系统成分的分布。解剖20个壁血栓和剩余的AAA壁。腔,中间和无腔血栓层以及培养基和外膜分别在细胞培养基中孵育。然后分析条件培养基中的纤溶酶原激活物(PAs),纤溶酶原激活物抑制剂1(PAI-1),游离纤溶酶,纤溶酶α(2)-抗纤溶酶复合物(PAP)和D-二聚体释放。并行地,通过RT-PCR进行PA和PAI-1mRNA表达分析。通过对这些成分进行AAA免疫组织化学定位,使用(99m)Tc-抑肽酶作为配体进行离体功能成像并测量PAP和D-二聚体血浆水平来完成该研究。所有纤溶系统成分均存在于每个动脉瘤层中。然而,壁血栓是丝氨酸蛋白酶活性释放的主要来源。有趣的是,血栓的腔层释放了大量的PAP和D-二聚体。这与纤溶酶原和PA的优先免疫定位相平行,并且在血栓的腔极中观察到(99m)Tc-抑肽酶闪烁显像信号。相反,mRNA表达分析显示tPA和PAI-1在壁内独家合成,而uPA mRNA也在血栓内表达。综上所述,这些结果表明,在AAA患者中发现的PAP和D-二聚体的血浆浓度升高与壁血栓蛋白水解活性有关,从而解释了它们与AAA进展的已知联系。纤溶系统的组件也可能代表AAA中血栓活动功能成像的目标。由John Wiley&Sons,Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号